Skip to content
Clinical Trials – home
Bayer Consumer Care AG
Sponsor

Bayer Consumer Care AG

Peter Merian-Strasse 84, 4052

About the sponsor

Clinical research includes metastatic castration-resistant prostate cancer, metastatic hormone-sensitive prostate cancer, biochemically recurrent prostate cancer, and broader advanced solid tumors. The portfolio also covers PSMA-expressing disease and hepatocellular carcinoma, with interest in tumor control and disease progression across advanced oncology settings.

  • PSMA-targeted prostate cancer
  • metastatic hormone-sensitive prostate cancer
  • hepatocellular carcinoma
  • advanced solid tumors

Additional activity extends to radionuclide therapy and androgen deprivation therapy in prostate cancer, reflecting sustained involvement in treatment areas linked to advanced genitourinary malignancies.

About Specializations

Bayer Consumer Care AG runs clinical trials in conditions such as Neoplasm malignant, Menopausal symptoms, Testosterone deficiency syndrome, Hot flush, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

14 clinical trials

Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Acoramidis
  • Sponsor:Bayer Consumer Care AG
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Bay 2927088
  • Sponsor:Bayer AG
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG
Countries:GermanyGermany
  • Participants:18–64 years · Healthy volunteers
  • Substances:Elinzanetant
  • Sponsor:Bayer AG
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years · Healthy volunteers
  • Substances:Dabigatran Etexilate
  • Sponsor:Bayer AG
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Abiraterone Acetate
  • Sponsor:Bayer AG
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Elinzanetant
  • Sponsor:Bayer AG

Sleep disorder+1

Not recruiting
Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Elinzanetant
  • Sponsor:Bayer AG
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Damoctocog Alfa Pegol
  • Sponsor:Bayer AG
Countries:CzechiaCzechia
  • Participants:0–17 years · 18–64 years
  • Substances:Larotrectinib Sulfate
  • Sponsor:Bayer AG
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Larotrectinib Sulfate
  • Sponsor:Bayer AG
Registered drug
Countries:LatviaLatvia
  • Participants:18–64 years · 65+ years
  • Substances:Darolutamide
  • Sponsor:Bayer AG

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.